Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports the formation of targeted therapies by enabling selective binding to enzyme active sites. Commonly employed in medicinal chemistry for constructing bioactive molecules due to the presence of reactive bromine and the tetrazole ring, which enhances metabolic stability and solubility. Also utilized in the preparation of antiviral agents and in research related to central nervous system disorders.